BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4603692)

  • 1. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes].
    Blumenbach L; Kiesselbach NH; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):437-46. PubMed ID: 4603692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 1. Establishment of proof and methods].
    Lehnert J; Kiesselbach NH; Blumenbach L
    Arzneimittelforschung; 1974 Mar; 24(0):433-7. PubMed ID: 4603693
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].
    Petzoldt R; Riedesel G; Ramrath M; Grabs V; Haupt E; Schwedes U; Ewald W; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):429-32. PubMed ID: 4603399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). 3. Results of tolerance tests].
    Kiesselbach NH; Blumenbach L; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):447-52. PubMed ID: 4603694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with prodiaban in diabetes mellitus].
    Gross W
    MMW Munch Med Wochenschr; 1974 Aug; 116(35):1509-12. PubMed ID: 4214136
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress in oral antidiabetic therapy].
    Rambert P
    Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
    Parodi FA
    Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Survey of 832 case records of diabetes of adult onset treated by Diamicron. Evolution of metabolism and weight].
    Estivals JP; Giraudet MC; Videau JY
    Journ Annu Diabetol Hotel Dieu; 1978; ():333-40. PubMed ID: 349228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
    Leubner H
    Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
    Vernet A; Fabre J; Zahnd G
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes therapy with a new antidiabetic Pro-Diaban].
    Dols W
    Ther Ggw; 1976 Mar; 115(3):428-36. PubMed ID: 772866
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multicenter study of the therapeutic efficiency of glycvidone (Beglynor)].
    Lepsanović L; Savić M
    Med Pregl; 1989; 42(11-12):434-7. PubMed ID: 2701890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
    Forattini C
    Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
    [No Abstract]   [Full Text] [Related]  

  • 19. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
    Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
    Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.